Literature DB >> 28414002

Global importation and population risk factors for measles in New Zealand: a case study for highly immunized populations.

D T S Hayman1, J C Marshall1, N P French1, T E Carpenter2, M G Roberts3, T Kiedrzynski4.   

Abstract

As endemic measles is eliminated through immunization, countries must determine the risk factors for the importation of measles into highly immunized populations to target control measures. Despite eliminating endemic measles, New Zealand suffers from outbreaks after introductions from abroad, enabling us to use it as a model for measles introduction risk. We used a generalized linear model to analyze risk factors for 1137 measles cases from 2007 to June 2014, provide estimates of national immunity levels, and model measles importation risk. People of European ethnicity made up the majority of measles cases. Age is a positive risk factor, particularly 0-2-year-olds and 5-17-year-old Europeans, along with increased wealth. Pacific islanders were also at greater risk, but due to 0-2-year-old cases. Despite recent high measles, mumps, and rubella vaccine immunization coverage, overall population immunity against measles remains ~90% and is lower in people born between 1982 and 2005. Greatest measles importation risk is during December, and countries predicted to be sources have historical connections and highest travel rates (Australia and UK), followed by Asian countries with high travel rates and higher measles incidences. Our results suggest measles importation due to travel is seeding measles outbreaks, and immunization levels are insufficient to continue to prevent outbreaks because of heterogeneous immunity in the population, leaving particular age groups at risk.

Entities:  

Keywords:  Control; measles (rubeola); public health; vaccination (immunization)

Mesh:

Year:  2017        PMID: 28414002      PMCID: PMC9203312          DOI: 10.1017/S0950268817000723

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  13 in total

1.  Predicting and preventing measles epidemics in New Zealand: application of a mathematical model.

Authors:  M G Roberts; M I Tobias
Journal:  Epidemiol Infect       Date:  2000-04       Impact factor: 2.451

2.  Estimation of measles reproduction ratios and prospects for elimination of measles by vaccination in some Western European countries.

Authors:  J Wallinga; D Lévy-Bruhl; N J Gay; C H Wachmann
Journal:  Epidemiol Infect       Date:  2001-10       Impact factor: 2.451

3.  Analysis of the Auckland 2014 measles outbreak indicates that adolescents and young adults could benefit from catch-up vaccination.

Authors:  Gary Reynolds; Cassandra Dias; Simon Thornley; Ronald King; Anne Morrison; Angela Matson; Richard Hoskins
Journal:  N Z Med J       Date:  2015-09-25

4.  Childhood immunisations in Northland, New Zealand: declining care and the journey through the immunisation pathway.

Authors:  Juliet Rumball-Smith; Timothy Kenealy
Journal:  N Z Med J       Date:  2016-07-15

5.  Measles, mumps, and rubella antibodies in children 5-6 years after immunization: effect of vaccine type and age at vaccination.

Authors:  N Boulianne; G De Serres; S Ratnam; B J Ward; J R Joly; B Duval
Journal:  Vaccine       Date:  1995-11       Impact factor: 3.641

6.  Risk factors for transmission of measles during an outbreak: matched case-control study.

Authors:  D Hungerford; P Cleary; S Ghebrehewet; A Keenan; R Vivancos
Journal:  J Hosp Infect       Date:  2013-12-21       Impact factor: 3.926

7.  Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage.

Authors:  Sandra Waaijenborg; Susan J M Hahné; Liesbeth Mollema; Gaby P Smits; Guy A M Berbers; Fiona R M van der Klis; Hester E de Melker; Jacco Wallinga
Journal:  J Infect Dis       Date:  2013-05-08       Impact factor: 5.226

8.  Effect of socioeconomic deprivation on uptake of measles, mumps and rubella vaccination in Liverpool, UK over 16 years: a longitudinal ecological study.

Authors:  D Hungerford; P Macpherson; S Farmer; S Ghebrehewet; D Seddon; R Vivancos; A Keenan
Journal:  Epidemiol Infect       Date:  2015-11-06       Impact factor: 2.451

9.  Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines.

Authors:  E Miller; A Hill; P Morgan-Capner; T Forsey; M Rush
Journal:  Vaccine       Date:  1995-06       Impact factor: 3.641

10.  Progress toward regional measles elimination--worldwide, 2000-2013.

Authors:  Robert T Perry; Marta Gacic-Dobo; Alya Dabbagh; Mick N Mulders; Peter M Strebel; Jean-Marie Okwo-Bele; Paul A Rota; James L Goodson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-11-14       Impact factor: 17.586

View more
  3 in total

Review 1.  Spread of Measles in Europe and Implications for US Travelers.

Authors:  Kristina M Angelo; Paul A Gastañaduy; Allison T Walker; Manisha Patel; Susan Reef; C Virginia Lee; Jeffrey Nemhauser
Journal:  Pediatrics       Date:  2019-06-17       Impact factor: 7.124

2.  Air Passenger Travel and International Surveillance Data Predict Spatiotemporal Variation in Measles Importations to the United States.

Authors:  Marya L Poterek; Moritz U G Kraemer; Alexander Watts; Kamran Khan; T Alex Perkins
Journal:  Pathogens       Date:  2021-02-03

3.  Gender differences in measles incidence rates in a multi-year, pooled analysis, based on national data from seven high income countries.

Authors:  Manfred S Green; Naama Schwartz; Victoria Peer
Journal:  BMC Infect Dis       Date:  2022-04-11       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.